期刊文献+

siRNA干扰FoxM1基因表达对人骨肉瘤MG63细胞增殖与凋亡影响研究 被引量:11

Effects of siRNA interfering the expression of FoxM1 on the proliferation and apoptosis in human osteosarcoma cell line MG63
原文传递
导出
摘要 目的通过抑制骨肉瘤细胞株MG63中FoxM1基因表达,观察对骨肉瘤细胞系增殖与凋亡的影响。方法采用蛋白质印迹法检测不同人骨肉瘤细胞株MG63和SOSP-9607中FoxM1基因的表达。将骨肉瘤细胞株MG63分为实验组、阴性对照组和空白对照组,实验组转染FoxM1特异性siRNA(FoxM1-siRNA),阴性对照组转染阴性对照siRNA,空白对照组不做处理。实时-聚合酶链反应(Real-time PCR)和蛋白质印迹法检测转染前后FoxM1基因在mRNA及蛋白表达水平的变化;四甲基偶氮唑盐(MTT)比色法检测细胞增殖率,流式细胞仪测定细胞凋亡率。结果人骨肉瘤细胞株MG63和SOSP-9607中存在FoxM1基因的表达。实验组MG63细胞转染siRNA后,FoxM1的mRNA表达为0.39±0.09,低于阴性对照组的0.91±0.07,t=7.92,P<0.001;也低于空白对照组的0.96±0.08,t=8.68,P<0.001。实验组FoxM1蛋白表达为0.31±0.06,显著低于阴性对照组的0.81±0.10,t=7.20,P<0.001;也低于空白对照组的0.89±0.09,t=8.35,P<0.001。实验组MG63细胞增殖率为0.36±0.03,显著低于阴性对照组的0.61±0.02,t=12.86,P<0.001;也低于空白对照组的0.65±0.02,t=14.92,P<0.001。实验组MG63细胞凋亡率为(13.69±1.15)%,显著高于阴性对照组的(2.38±0.90)%,t=14.16,P<0.001;也高于空白对照组的(2.87±0.86)%,t=13.54,P<0.001。结论人骨肉瘤细胞株中存在FoxM1蛋白的表达;特异性siRNA可下调骨肉瘤细胞株MG63中FoxM1基因的表达,对细胞的增殖具有负性调控作用,并能诱导细胞凋亡。 OBJECTIVE To detect the expression of FoxM1 in the human osteosarcoma cell line MG63 and SOSP-9607,and to investigate the influence of suppression of the expression of FoxM1 on proliferation and apoptosis in human osteosarcoma cell line MG63 and explore the role FoxM1 played in the pathogenesis of osteosarcoma.METHODSThe expression of FoxM1 was detected by Western-blot in osteosarcoma cell line MG63 and SOSP-9607.MG63 cells were divided into three groups:experimental group,negative control group and blank group.FoxM1-targeted siRNA and control siRNA were transfected into MG63 cells in experimental group and negative control group,respectively.Real-time reverse transcription-polymerase chain reaction(RT-PCR)and Western blot were used to detect the expression of mRNA and protein of FoxM1.MTT assay was used to detect the proliferation of MG63 cells and apoptosis was measured by flow cytometry.RESULTS The results of Western-blot showed that the expression of FoxM1 was detected in the human osteosarcoma cell line MG63 and SOSP-9607.FoxM1-targeted siRNA was successfully transfected into MG63 cells,leading to the significant inhibition of FoxM1 gene expression at both mRNA(0.39±0.09)and protein level(0.31±0.06)compared with negative control group(0.91±0.07,0.81±0.10)and blank group(0.96±0.08,0.89±0.09),P0.001 for each.The MTT assay showed that FoxM1-targeted siRNA inhibited the proliferation of MG63 cells in experimental group(0.36±0.03)compared with two control groups(0.61±0.02,0.65±0.02,P0.001 for each).Results of FCM pointed that the apoptosis ratio of experimental group(13.69±1.15)was significant higher than that of negative control group(2.38±0.90)and blank group(2.87±0.86,P0.001 for each).CONCLUSIONS In vitro,FoxM1-targeted siRNA could effectively inhibit the expression of FoxM1 at both mRNA and protein level in human osteosarcoma cell line MG63.Downregulation of FoxM1 expression could inhibit cell proliferation of MG63 cells and induce cell apoptosis.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第20期1575-1579,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81072194)
关键词 骨肉瘤 FOXM1 RNA干扰 细胞增殖 细胞凋亡 印迹法 蛋白质 osteosarcoma FoxM1 RNAi proliferation apoptosis blotting western
  • 相关文献

参考文献20

  • 1杨彤涛,张志培,李存孝,高杰,张勇,周勇,范清宇,马保安.RNA干涉技术抑制骨肉瘤细胞MG63中Survivin基因表达的研究[J].中华肿瘤防治杂志,2007,14(10):744-748. 被引量:3
  • 2王威,毕文志.骨肉瘤治疗现状与展望[J].解放军医学院学报,2013,34(2):198-200. 被引量:17
  • 3Schwab JH, Springfield DS, Raskin KA, et al. What's new in primary bone tumors[J]. J Bone Joint Surg Am,2012,94(20): 1913-1919. 被引量:1
  • 4Korver W, Roose J. The winged-helix transcription factor Tri- dent is expressed in cycling cells[J]. Nucleic Acids Res, 1997, 25(9) :1715-1719. 被引量:1
  • 5Yao KM, Sha M, Lu Z, et al. Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding do- main[J]. J BioI Chem, 1997,272(32) :1927-1936. 被引量:1
  • 6Wierstra I, Alves J. FoxM1 a typical proliferation-associated transcription factor[J]. Biol Chem, 2007,388 (12) : 1257-1274. 被引量:1
  • 7Gialmanidis IP,Bravou V, Amanetopoulou SG, et al. Overexpres-sion of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas[J]. Lung Cancer, 2009,66 (1) : 64-74. 被引量:1
  • 8Yang C, Chen H, Tan G, et al. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancerFJ]. Cancer letters, 2013, 340(1) : 104-112. 被引量:1
  • 9Cai Y, Balli D, Ustiyan V, et al. Foxml expression in prostate epithelial cells is essential for prostate carcinogenesis[J]. J Biol Chem, 2013, 288(31): 22527-22541. 被引量:1
  • 10Wierstra I, Alves .l. FoxMlc is activated by cyclin E/Cdk2, cyc- lin A/Cdk2, and cyclin A/Cdkl, but repressed by GSK-Salpha [J]. Biochem Biophys Res Commun, 2006,348 ( 1 ) : 99-108. 被引量:1

二级参考文献81

  • 1李文雁,祝淑钗.Survivin基因与肿瘤治疗策略[J].肿瘤防治杂志,2005,12(19):1513-1516. 被引量:1
  • 2Campanacci M. Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. New York: Springer Verlag Wien, 1999: 464-491. 被引量:1
  • 3Rosen G, Tan C, Sanmaneechai A, et al. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma. Cancer, 1975, 35(3 suppl): 936-945. 被引量:1
  • 4Jaffe N. Osteosarcoma: review of the past, impact on the future. The American experience. Cancer Treat Res, 2010, 152: 239-262. 被引量:1
  • 5Kim Hi, Chalmers PN, Morris CD. Pediatric osteogenic sarcoma. Curr Opin Pediatr, 2010, 22(1): 61-66. 被引量:1
  • 6Evans AE. Mitomycin C. Cancer Chemother Rep, 1961, 14: 1-9. 被引量:1
  • 7Rosen G, Marcove RC, Caparros B, et al. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer, 1979, 43(6): 2163-2177. 被引量:1
  • 8Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer, 1982, 49(6): 1221-1230. 被引量:1
  • 9Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol, 2002, 20(3): 776-790. 被引量:1
  • 10Oka K, Yakushiji T, Sato H, et al. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol, 2010, 39(2): 141-146. 被引量:1

共引文献41

同被引文献60

  • 1赵亚恒,冯和林,郑丽华,贾志峰,冯建刚.骨肉瘤发病机制的研究进展[J].肿瘤防治研究,2014,41(3):283-286. 被引量:25
  • 2孙成群,郭风劲,许涛,王俊方,陈安民.极低频率电磁场对离体肿瘤细胞的诱导凋亡作用[J].肿瘤防治研究,2007,34(1):47-50. 被引量:6
  • 3Broadhead ML, Clark JC, Myers DE, et al. The molecular pathogenesis of osteosarcoma: a review [J]. Sarcoma, 2011, 2011: 959248. 被引量:1
  • 4Bielack SS, Carrie D, Hardes J, et al. Bone tumors in adolescents and young adults[J]. Curr Treat Options Oncol, 2008, 9(1): 67-80. 被引量:1
  • 5Gargett T, Brown MP. The inducible caspase-9 suicide gene system as a "safety switch" to limit on-target, off-ttunor toxicities of chimeric antigen receptor T cells[J]. Front Pharmacol, 2014, 5:235. 被引量:1
  • 6Sakamoto A, Iwamoto Y. Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy[J]. Rev Recent Clin Trials, 2008, 3(3): 228-231. 被引量:1
  • 7Chou AJ, Geller DS, Gorlick R. Therapy for osteosarcoma: where do we go fi'om here?[J]. Paediatr Drugs, 2008, 10(5): 315-327. 被引量:1
  • 8Williams CD, Markov MS, Hardman WE, et al. Therapeutic electromagnetic field effects on angiogenesis and tumor growth [J]. Antieancer Re-search, 2001, 21(6A): 3887-3891. 被引量:1
  • 9Zhao G, Lin X, Zhou M, et al. Relationship between exposure to extremely low-frequency electromagnetic fields and breast cancer risk: a meta-analysis[J]. Eur J Gynaecol Oncol, 2014, 35(3): 264-269. 被引量:1
  • 10Chen Q, Lang L, Wu W, et al. A meta-analysis on the relationship between exposure to ELF-EMFs and the risk of female breast cancer [J]. PLoS One, 2013, 8(7): e69272. 被引量:1

引证文献11

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部